India to Sri Lanka: Celecoxib Export Trade Route
India has recorded 103 verified shipments of Celecoxib exported to Sri Lanka, representing a combined trade value of $2.7M USD. This corridor is served by 16 active Indian exporters, with an average shipment value of $26.6K USD. The leading Indian exporter is ZYDUS LIFESCIENCES LIMITED , which accounts for 39% of total export value with 23 shipments worth $1.1M USD. On the buying side, SUNSHINE HEALTHCARE LANKA LIMITED is the largest importer in Sri Lanka with $823.6K USD in purchases. The top 3 suppliers — ZYDUS LIFESCIENCES LIMITED , ZYDUS LIFESCIENCES LIMITED, CADILA HEALTHCARE LIMITED — together control 71% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Sri Lanka Celecoxib corridor is one of India's established pharmaceutical export routes, with 103 shipments documented worth a combined $2.7M USD. The route is dominated by ZYDUS LIFESCIENCES LIMITED , which alone accounts for roughly 39% of all export value, reflecting the consolidated nature of India's celecoxib manufacturing sector.
Across 16 active suppliers, the average shipment value stands at $26.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (69%) and air (18%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during October–December, with an average transit time of 17 days port-to-port. The route has recorded an annual growth rate of 26.5%, placing it at rank #10 among India's top celecoxib export destinations globally.
On the import side, key buyers of Indian celecoxib in Sri Lanka include SUNSHINE HEALTHCARE LANKA LIMITED, SUNSHINE HEALTHCARE LANKA LIMITED , STATE PHARMACEUTICALS and 21 others. SUNSHINE HEALTHCARE LANKA LIMITED is the single largest importer with 23 shipments valued at $823.6K USD.
Route Characteristics
- Average transit17 days
- Peak seasonQ4
- Primary modeMulti-modal
- Top portNHAVA SHEVA SEA (INNSA1)
Market Position
- Global rank#10
- Annual growth+26.5%
- Demand growth+22.3%
- Regulatory ease69/100
Top 10 Indian Celecoxib Exporters to Sri Lanka
Showing top 10 of 16 Indian suppliers exporting Celecoxib to Sri Lanka, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | ZYDUS LIFESCIENCES LIMITED Avg $46.7K per shipment | 23 | $1.1M | 39.2% |
| 2 | ZYDUS LIFESCIENCES LIMITED Avg $26.0K per shipment | 23 | $599.1K | 21.9% |
| 3 | CADILA HEALTHCARE LIMITED Avg $28.9K per shipment | 9 | $260.0K | 9.5% |
| 4 | UNICHEM LABORATORIES LIMITED Avg $25.7K per shipment | 8 | $205.6K | 7.5% |
| 5 | CADILA HEALTHCARE LTD Avg $53.3K per shipment | 3 | $160.0K | 5.8% |
| 6 | THE MADRAS PHARMACEUTICALS Avg $107.1K per shipment | 1 | $107.1K | 3.9% |
| 7 | UNOSOURCE PHARMA LIMITED Avg $8.0K per shipment | 13 | $104.6K | 3.8% |
| 8 | KOPRAN LIMITED Avg $22.6K per shipment | 3 | $67.9K | 2.5% |
| 9 | ZIM LABORATORIES LIMITED. Avg $9.1K per shipment | 4 | $36.5K | 1.3% |
| 10 | UNICURE REMEDIES PRIVATE LIMITED Avg $6.7K per shipment | 5 | $33.4K | 1.2% |
This table shows the top 10 of 16 Indian companies exporting celecoxib to Sri Lanka, ranked by total trade value. The listed exporters are: ZYDUS LIFESCIENCES LIMITED , ZYDUS LIFESCIENCES LIMITED, CADILA HEALTHCARE LIMITED, UNICHEM LABORATORIES LIMITED, CADILA HEALTHCARE LTD, THE MADRAS PHARMACEUTICALS, UNOSOURCE PHARMA LIMITED, KOPRAN LIMITED, ZIM LABORATORIES LIMITED. , UNICURE REMEDIES PRIVATE LIMITED. ZYDUS LIFESCIENCES LIMITED is the dominant supplier with 23 shipments worth $1.1M USD, giving it a 39% market share. The top 3 suppliers together account for 71% of the total trade value on this route.
Showing top 10 of 16 total Indian exporters on the India to Sri Lanka Celecoxib export route.
Top 10 Celecoxib Importers in Sri Lanka
Showing top 10 of 24 known buyers in Sri Lanka receiving Celecoxib shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian celecoxib in Sri Lanka include SUNSHINE HEALTHCARE LANKA LIMITED, SUNSHINE HEALTHCARE LANKA LIMITED , STATE PHARMACEUTICALS , STATE PHARMACEUTICALS, TO THE ORDER OF, among 24 total buyers. The largest importer is SUNSHINE HEALTHCARE LANKA LIMITED, accounting for $823.6K USD across 23 shipments — representing 30% of all celecoxib imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SUNSHINE HEALTHCARE LANKA LIMITED | 23 | $823.6K | 30.0% |
| 2 | SUNSHINE HEALTHCARE LANKA LIMITED | 17 | $558.7K | 20.4% |
| 3 | STATE PHARMACEUTICALS | 6 | $515.0K | 18.8% |
| 4 | STATE PHARMACEUTICALS | 9 | $174.9K | 6.4% |
| 5 | TO THE ORDER OF | 8 | $145.7K | 5.3% |
| 6 | TO THE ORDER OF.. | 2 | $114.5K | 4.2% |
| 7 | STATE PHARMACEUTICALS CORPORATION | 1 | $107.1K | 3.9% |
| 8 | DARLEY BUTLER CO LIMITED | 10 | $82.2K | 3.0% |
| 9 | TABRANE PHARMACEUTICALS PVT LTD | 4 | $36.5K | 1.3% |
| 10 | TO THE ORDER OF | 1 | $24.3K | 0.9% |
Showing top 10 of 24 Celecoxib importers in Sri Lanka on this route.
Top 10 Celecoxib Formulations Imported by Sri Lanka
Showing top 10 of 63 product formulations shipped on the India to Sri Lanka Celecoxib route, ranked by trade value
Sri Lanka imports a wide range of celecoxib formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — CELECOXIB CAPSULES 100MG CELECOXIB 10X10 — accounts for $398.0K USD across 1 shipments. There are 63 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CELECOXIB CAPSULES 100MG CELECOXIB 10X10 | 1 | $398.0K | 14.5% |
| 2 | ZYCEL 200MG CAPSULESCELECOXIB10X10 | 7 | $231.2K | 8.4% |
| 3 | ZYCEL 200MG CAPSULES(CELECOXIB)(10X10) | 4 | $227.7K | 8.3% |
| 4 | ZYCEL 100MG CAPSULES(CELECOXIB)(10X10) | 5 | $167.5K | 6.1% |
| 5 | ZYCEL 200MG CAPS CELECOXIB CAPS 10X10SHIPMENT UNDER LUT No AD300325000368N Dated 10 03 2025 valid up to 31 03 2026 | 1 | $125.0K | 4.6% |
| 6 | CELECOXIB CAPSULES 200 MG NIMERAL 200 10X10 S | 1 | $107.1K | 3.9% |
| 7 | ZYCEL 100MG CAPSULESCELECOXIB10X10 | 3 | $90.0K | 3.3% |
| 8 | ZYCEL 200MG CAPSULES CELECOXIB 10X10 | 1 | $86.2K | 3.1% |
| 9 | ZYCEL 100 (CELECOXIB CAPS) 10X10 SHIPMENT UNDER LUT No.AD300324000860V Dated 21.03.2024 valid up to 31.03.2025 | 2 | $85.1K | 3.1% |
| 10 | HARMLESS MEDICINES : UNICELIB 200MG CAPSULESCelecoxib Capsules10X 10(11,506 PACK X10X10 CAP = 1150600 CAPSUL | 1 | $79.3K | 2.9% |
Showing top 10 of 63 Celecoxib formulations imported by Sri Lanka on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 69% sea for bulk, 18% air for urgent orders.
Top Ports of Origin
NHAVA SHEVA SEA (INNSA1) handles the highest volume with 29 shipments. Transit time averages 17 days by sea.
Market Dynamics
India's celecoxib exports to Sri Lanka are driven primarily by a handful of large-scale manufacturers. ZYDUS LIFESCIENCES LIMITED with 23 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 16 active exporters signals a competitive but concentrated market — buyers in Sri Lanka benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — ZYDUS LIFESCIENCES LIMITED , ZYDUS LIFESCIENCES LIMITED, CADILA HEALTHCARE LIMITED — together account for 71% of total trade value on this route. The average shipment value of $26.6K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as zycel 200mg capsulescelecoxib10x10 and zycel 200mg capsules(celecoxib)(10x10), suggesting that buyers in Sri Lanka tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, SUNSHINE HEALTHCARE LANKA LIMITED is the largest importer with 23 shipments worth $823.6K USD — representing 30% of all celecoxib imports from India on this route. A total of 24 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $2.7M
- Avg. Shipment
- $26.6K
- Suppliers
- 16
- Buyers
- 24
- Transit (Sea)
- ~17 days
- Annual Growth
- +26.5%
Other Celecoxib Routes
Unlock the Full India to Sri Lanka Celecoxib Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 103 shipments on this route.
Frequently Asked Questions — India to Sri Lanka Celecoxib Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Celecoxib to Sri Lanka?
The leading Indian exporters of Celecoxib to Sri Lanka are ZYDUS LIFESCIENCES LIMITED , ZYDUS LIFESCIENCES LIMITED, CADILA HEALTHCARE LIMITED. ZYDUS LIFESCIENCES LIMITED holds the largest market share at approximately 39% of total trade value on this route.
Q What is the total value of Celecoxib exports from India to Sri Lanka?
India exports Celecoxib to Sri Lanka worth approximately $2.7M USD across 103 recorded shipments. The average value per shipment is $26.6K USD.
Q Which ports does India use to ship Celecoxib to Sri Lanka?
The most active port of origin is NHAVA SHEVA SEA (INNSA1) with 29 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 69% of shipments going by sea and 18% by air.
Q How long does shipping take from India to Sri Lanka for Celecoxib?
The average transit time for Celecoxib shipments from India to Sri Lanka is approximately 17 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to Sri Lanka Celecoxib trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 26.5% with demand growth tracking at 22.3%. The route is ranked #10 among India's top Celecoxib export destinations globally.
Q How many suppliers are active on the India to Sri Lanka Celecoxib route?
There are currently 16 active Indian suppliers exporting Celecoxib to Sri Lanka. The market is moderately concentrated with ZYDUS LIFESCIENCES LIMITED accounting for 39% of total shipment value.
Q Who are the main importers of Celecoxib from India in Sri Lanka?
The leading importers of Indian Celecoxib in Sri Lanka include SUNSHINE HEALTHCARE LANKA LIMITED, SUNSHINE HEALTHCARE LANKA LIMITED , STATE PHARMACEUTICALS , STATE PHARMACEUTICALS, TO THE ORDER OF. SUNSHINE HEALTHCARE LANKA LIMITED is the largest buyer with 23 shipments worth $823.6K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Sri Lanka export trade corridor identified from Indian Customs (DGFT) records for Celecoxib.
- 2.Supplier/Buyer Matching: 16 Indian exporters and 24 importers in Sri Lanka matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 103 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
103 Verified Shipments
16 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists